Home Cart Sign in  
Chemical Structure| 144506-14-9 Chemical Structure| 144506-14-9

Structure of Licochalcone C
CAS No.: 144506-14-9

Chemical Structure| 144506-14-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Licochalcone C inhibits α-glucosidase with IC50 values of <100 nM for α-glucosidase and 92.43 μM for protein tyrosine phosphatase 1B.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Licochalcone C

CAS No. :144506-14-9
Formula : C21H22O4
M.W : 338.40
SMILES Code : O=C(C1=CC=C(O)C=C1)/C=C/C2=CC=C(O)C(CC=C(C)C)=C2OC
MDL No. :MFCD20527293

Safety of Licochalcone C

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
human liver microsomes 6.02 μM 3 min and 33 min preincubation Evaluate the inhibitory effect of Licochalcone C on CYP3A, showing time-dependent inhibition with IC50 decreasing from 6.02 μM to 2.51 μM Acta Pharmacol Sin. 2022 Apr;43(4):1072-1081
H9c2 cells 1–250 µM 24 hours To evaluate the inhibitory effect of LicoC on LPS-induced ROS generation, results showed that LicoC significantly reduced intracellular ROS accumulation. Int J Mol Sci. 2017 Mar 23;18(4):690
H9c2 cells 25 µM 24 hours To evaluate the protective effect of LicoC against LPS-induced cytotoxicity, results showed that LicoC significantly protected cells from LPS-induced cell death. Int J Mol Sci. 2017 Mar 23;18(4):690
H9c2 cells 1–500 µM 48 hours To evaluate the effect of LicoC on H9c2 cell viability, results showed no significant effect on cell viability at concentrations up to 250 µM. Int J Mol Sci. 2017 Mar 23;18(4):690
HSC3 cells 10, 20, 30 µM 24 and 48 hours LCH reduced the viability of HSC3 cells and induced cell cycle arrest and apoptosis. Oncol Rep. 2019 Jan;41(1):333-340
HSC2 cells 10, 20, 30 µM 24 and 48 hours LCH reduced the viability of HSC2 cells and induced cell cycle arrest and apoptosis. Oncol Rep. 2019 Jan;41(1):333-340
JB6 cells 5, 10, 20 μM 24 or 48 hours To evaluate the antiproliferative effect of LCC on JB6 cells, results showed that LCC did not exhibit noticeable cytotoxicity at 20 μM. Biomol Ther (Seoul). 2024 Jan 1;32(1):104-114
HaCaT cells 5, 10, 20 μM 24 or 48 hours To evaluate the antiproliferative effect of LCC on HaCaT cells, results showed that LCC did not exhibit noticeable cytotoxicity at 20 μM. Biomol Ther (Seoul). 2024 Jan 1;32(1):104-114
HCT116-OxR cells 5, 10, 20 μM 24 or 48 hours To evaluate the antiproliferative effect of LCC on HCT116-OxR cells, results showed that LCC inhibited cell growth in a concentration- and time-dependent manner. Biomol Ther (Seoul). 2024 Jan 1;32(1):104-114
HCT116 cells 5, 10, 20 μM 24 or 48 hours To evaluate the antiproliferative effect of LCC on HCT116 cells, results showed that LCC inhibited cell growth in a concentration- and time-dependent manner. Biomol Ther (Seoul). 2024 Jan 1;32(1):104-114
JB6 4, 8, 12 µM 24 or 48 hours LCH did not show cytotoxicity in JB6 cells. Biomol Ther (Seoul). 2023 Nov 1;31(6):661-673
HaCaT 4, 8, 12 µM 24 or 48 hours LCH did not show cytotoxicity in HaCaT cells. Biomol Ther (Seoul). 2023 Nov 1;31(6):661-673
HCT116-OxR 4, 8, 12 µM 24 or 48 hours LCH significantly inhibited cell viability and colony growth in HCT116-OxR cells and induced apoptosis. Biomol Ther (Seoul). 2023 Nov 1;31(6):661-673
HCT116 4, 8, 12 µM 24 or 48 hours LCH significantly inhibited cell viability and colony growth in HCT116 cells and induced apoptosis. Biomol Ther (Seoul). 2023 Nov 1;31(6):661-673
Vero 27.7 mg/mL 24 hours Evaluate the cytotoxicity of Licochalcone C on Vero cells Front Microbiol. 2019 Nov 5;10:2489
HepG2 50.8 mg/mL 24 hours Evaluate the cytotoxicity of Licochalcone C on HepG2 cells Front Microbiol. 2019 Nov 5;10:2489
THP-1 (human myelomonocytic leukemia cells) 50 μM 24 hours To evaluate the antioxidant effects of Licochalcone C on LPS and IFN-γ-induced inflammatory responses. Results showed that Licochalcone C significantly decreased the expression and activity of iNOS via the NF-κB pathway, reduced superoxide anion (O2−) production, and modulated the antioxidant network activity of SOD, CAT, and GPx. Pharmaceuticals (Basel). 2024 May 14;17(5):634
THP-1 (human myelomonocytic leukemia cells) 50 μM 24 hours To evaluate the antioxidant effects of Licochalcone C on LPS and IFN-γ-induced inflammatory responses. Results showed that Licochalcone C significantly decreased the expression and activity of iNOS via the NF-κB pathway, reduced superoxide anion (O2−) production, and modulated the antioxidant network activity of SOD, CAT, and GPx. Molecules. 2011 Jul 6;16(7):5720-34
MRSA T144 4 mg/mL Evaluate the antibacterial activity of Licochalcone C against MRSA T144 Front Microbiol. 2019 Nov 5;10:2489
MSSA ATCC29213 4 mg/mL Evaluate the antibacterial activity of Licochalcone C against MSSA ATCC29213 Front Microbiol. 2019 Nov 5;10:2489

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.96mL

0.59mL

0.30mL

14.78mL

2.96mL

1.48mL

29.55mL

5.91mL

2.96mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories